September 17, 2012 – Millions of women chose NuvaRing contraceptive devices over birth control pills based on marketing claims that the vaginal rings would have fewer side effects.
Unfortunately, researchers have now found that the NuvaRing’s direct release of chemical hormones into the bloodstream may increase the risk of blood clots even more than traditional birth control pills.
The FDA has received more than 1,000 blood clot injury or death reports among NuvaRing patients. They also released a study in 2011 which showed vaginal ring contraceptives could increase the risks of blood clots by as much as 56%.
More than 1,000 patients have already filed a NuvaRing lawsuit over blood clot injuries. The claims have been consolidated into a federal Multi-District Litigation court in Missouri. Recently, Judge Sippel announced the first NuvaRing trials would start in May of 2013.
The start of NuvaRing side effect trials will set a precedent for other cases and could encourage settlement earlier than expected. Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after using the device should speak with a lawyer about their legal options as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, the Drug Resource Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
Contact us today for more information on research, side effects and litigation news related to NuvaRing devices, or to speak with a lawyer.